Clinical Trial Update: To Assess the Safety and Tolerability of Tafasitamab Alone or in Combination With Other Drugs in Japanese Participants With Non-Hodgkins Lymphoma (NHL) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial update assessing the safety and tolerability of tafasitamab alone or in combination with other drugs in Japanese participants with no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• Monjuvi (tafasitamab)

Snippet

Sponsor: Incyte Biosciences Japan GK | Conditions: Non Hodgkins Lymphoma, Diffuse Large B-cell Lymphoma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING